The role of antithrombin III in clinical management of pulmonary embolization.

[1]  B. Rothschild,et al.  Serine esterase inhibition and immune modulation. , 1984, Seminars in arthritis and rheumatism.

[2]  J H Lewis,et al.  Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. , 1983, The New England journal of medicine.

[3]  E. Eichner,et al.  Diagnosis of a persistent pulmonary embolus by indium- 111 platelet scintigraphy with angiographic and tissue confirmation. , 1982, The American journal of medicine.

[4]  W. Bell.  Pulmonary embolism: progress and problems. , 1982, The American journal of medicine.

[5]  H. Hassouna,et al.  Binding Of Thrombin By Plasma Inhibitors , 1981, Thrombosis and Haemostasis.

[6]  W. McCartney,et al.  The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. , 1981, The American journal of medicine.

[7]  T. H. Kam,et al.  Chronic persistent pulmonary embolism. Report of three cases. , 1980, The American journal of medicine.

[8]  D. Nilsen,et al.  An Attempt at Predicting Postoperative Deep Vein Thrombosis by Preoperative Coagulation Studies in Patients Undergoing Total Hip Replacement , 1980, Thrombosis and Haemostasis.

[9]  C. Gillet,et al.  Reliability of Amidolytic Assays for Progressive Antithrombin and Heparin Cofactor Activities on Capillary Blood , 1980, Thrombosis and Haemostasis.

[10]  R. Carrell,et al.  Active site of α1-antitrypsin: Homologous site in antithrombin-III , 1980 .

[11]  D. Hadden,et al.  Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy. , 1980, Haemostasis.

[12]  K. Jørgensen,et al.  Antithrombin III and the nephrotic syndrome. , 2009, Scandinavian journal of haematology.

[13]  J. Wilson,et al.  Diagnostic value of tests of fibrin metabolism in patients predisposed to pulmonary embolism. , 1979, Archives of internal medicine.

[14]  J. Vermylen,et al.  The role of the fibrinolytic system in thromboembolism. , 1979, Progress in cardiovascular diseases.

[15]  S Moncada,et al.  The role of prostacyclin in vascular tissue. , 1979, Federation proceedings.

[16]  G. Beller,et al.  Scintigraphic detection of pulmonary emboli by serial positron imaging of inhaled 15O-labeled carbon dioxide. , 1978, The New England journal of medicine.

[17]  P. Blatt,et al.  ANTITHROMBIN-III TRANSFUSION IN DISSEMINATED INTRAVASCULAR COAGULATION , 1978, The Lancet.

[18]  T. Barrowcliffe,et al.  Antithrombin III and heparin. , 1978, British medical bulletin.

[19]  E D Robin,et al.  Overdiagnosis and overtreatment of pulmonary embolism: the emperor may have no clothes. , 1977, Annals of internal medicine.

[20]  O. Odegård,et al.  Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). , 1977, Thrombosis research.

[21]  J. Gockerman,et al.  HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-III , 1977, The Lancet.

[22]  R. Bradshaw,et al.  Isolation of Antithrombin III from Normal and α1-Antitrypsin-Deficient Human Plasma , 1977, Thrombosis and Haemostasis.

[23]  M. Verstraete,et al.  Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration , 1977, European journal of clinical investigation.

[24]  R. Mason,et al.  The endothelium: roles in thrombosis and hemostasis. , 1977, Archives of pathology & laboratory medicine.

[25]  C. Ruckley,et al.  A 5 year follow up of lords dilation for hemorrhoids , 1976 .

[26]  I. Kovács,et al.  A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation. , 1976, Thrombosis research.

[27]  Rosenberg Rd,et al.  Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin. , 1976 .

[28]  J. Penner,et al.  Antithrombins: clinical aspects, chemical and biologic properties. , 1976, Progress in clinical and biological research.

[29]  E. Marciniak.  Adverse Effect of Heparin in Thrombin-Antithrombin III Interaction , 1975, Thrombosis and Haemostasis.

[30]  A. Gervin,et al.  Drug induced hypofibrinolysis: a cause of venous thrombosis. , 1975, The Journal of surgical research.

[31]  A. Teger‐Nilsson.  ANTITHROMBIN IN INFANCY AND CHILDHOOD , 1975 .

[32]  D. Pepper,et al.  Investigations on Antithrombin III in Normal Plasma and Serum , 1975, British journal of haematology.

[33]  D. Ogston,et al.  The action of antithrombin III on plasmin and activators of plasminogen. , 1975, Biochimica et biophysica acta.

[34]  R. Rosenberg.  Actions and interactions of antithrombin and heparin. , 1975, The New England journal of medicine.

[35]  E. Fonkalsrud,et al.  Effects on arterial intima of saline infusions. , 1974, The Journal of surgical research.

[36]  P. Desimone,et al.  Familial thrombosis due to antithrombin 3 deficiency. , 1974, Blood.

[37]  I. Nilsson,et al.  Antithrombin III in a clinical material , 1973 .

[38]  B. Binder.  On the complex formation of antithrombin 3 with thrombin. Gelfiltration studies on human plasma and serum. , 1973, Thrombosis et diathesis haemorrhagica.

[39]  M. Stemerman.  Thrombogenesis of the rabbit arterial plaque. An electron microscopic study. , 1973, The American journal of pathology.

[40]  I. Nilsson,et al.  New aspects of the pathogenesis of thrombo-embolism. , 1973, Progress in surgery.

[41]  R. Schlant,et al.  Chronic pulmonary arterial embolization or thrombosis. , 1971, The American journal of cardiology.

[42]  E. Frenkel,et al.  Spontaneous fibrinolysis in pulmonary embolism. , 1971, The Journal of clinical investigation.

[43]  U. Abildgaard,et al.  Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma. , 1970, Scandinavian journal of clinical and laboratory investigation.

[44]  R. Biggs,et al.  Antithrombin III, Antifactor Xa and Heparin , 1970 .

[45]  S. Wessler,et al.  Experimental hypercoagulable state induced by factor X: comparison of the nonactivated and activated forms. , 1968, The Journal of laboratory and clinical medicine.

[46]  H. Gans,et al.  Alpha-1-antitrypsin, an inhibitor for thrombin and plasmin. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[47]  U. Abildgaard.  Purification of Two Progressive Antithrombins of Human Plasma , 1967 .

[48]  U. Abildgaard.  Inhibition of the Thrombin-fibrinogen Reaction by Antithrombin III, Studied by N-terminal Analysis , 1967 .

[49]  A. Rimon,et al.  The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin. , 1966, The Journal of biological chemistry.

[50]  H. Kwaan,et al.  Fibrinolytic Activity in Thrombosed Veins , 1965, Circulation research.

[51]  I. Nilsson,et al.  Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. , 2009, Acta medica Scandinavica.